BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alexandre FR, Badaroux E, Bilello JP, Bot S, Bouisset T, Brandt G, Cappelle S, Chapron C, Chaves D, Convard T, Counor C, Da Costa D, Dukhan D, Gay M, Gosselin G, Griffon JF, Gupta K, Hernandez-Santiago B, La Colla M, Lioure MP, Milhau J, Paparin JL, Peyronnet J, Parsy C, Pierra Rouvière C, Rahali H, Rahali R, Salanson A, Seifer M, Serra I, Standring D, Surleraux D, Dousson CB. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors. Bioorg Med Chem Lett 2017;27:4323-30. [PMID: 28835346 DOI: 10.1016/j.bmcl.2017.08.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Yang W, Zheng S, He Y, Wang G, Qin H, Zhu F, Jiang X, Shen J, Gong X. Stereoselective Synthesis of 2-Deoxy-2-disubstituted ribonolactones Through a TiCl4-Mediated Evans-Aldol Reaction. Tetrahedron Letters 2022. [DOI: 10.1016/j.tetlet.2022.153728] [Reference Citation Analysis]
2 Dousson CB. Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection. Antivir Chem Chemother 2018;26:2040206618756430. [PMID: 29463095 DOI: 10.1177/2040206618756430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Serpi M, Pertusati F. An overview of ProTide technology and its implications to drug discovery. Expert Opin Drug Discov 2021;:1-13. [PMID: 33985395 DOI: 10.1080/17460441.2021.1922385] [Reference Citation Analysis]
4 Klapars A, Chung JYL, Limanto J, Calabria R, Campeau LC, Campos KR, Chen W, Dalby SM, Davis TA, DiRocco DA, Hyde AM, Kassim AM, Larsen MU, Liu G, Maligres PE, Moment A, Peng F, Ruck RT, Shevlin M, Simmons BL, Song ZJ, Tan L, Wright TJ, Zultanski SL. Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods. Chem Sci 2021;12:9031-6. [PMID: 34276931 DOI: 10.1039/d1sc01978c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xiang DF, Bigley AN, Desormeaux E, Narindoshvili T, Raushel FM. Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs. Biochemistry 2019;58:3204-11. [PMID: 31268686 DOI: 10.1021/acs.biochem.9b00530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Iwanejko J, Brol A, Szyja B, Daszkiewicz M, Wojaczyńska E, Olszewski TK. Hydrophosphonylation of chiral hexahydroquinoxalin-2(1H)-one derivatives as an effective route to new bicyclic compounds: Aminophosphonates, enamines and imines. Tetrahedron 2019;75:1431-9. [DOI: 10.1016/j.tet.2019.01.062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
7 Chris Krueger A, Chen HJ, Randolph JT, Brown BS, Halvorsen GT, Heyman HR, Li T, Marvin CC, Shanley JP, Voight EA, Bow DAJ, Van Handel C, Peterkin V, Carr RA, Stolarik D, Dekhtyar T, Irvin ML, Krishnan P, Henry RF, Wagner R, DeGoey DA. Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virus. Bioorg Med Chem 2020;28:115208. [PMID: 31740203 DOI: 10.1016/j.bmc.2019.115208] [Reference Citation Analysis]
8 Chung JYL, Kassim AM, Simmons B, Davis TA, Song ZJ, Limanto J, Dalby SM, He CQ, Calabria R, Wright TJ, Campeau L. Kilogram-Scale Synthesis of 2′- C -Methyl- arabino -Uridine from Uridine via Dynamic Selective Dipivaloylation. Org Process Res Dev . [DOI: 10.1021/acs.oprd.1c00175] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Patel D, Cox BD, Kasthuri M, Mengshetti S, Bassit L, Verma K, Ollinger-Russell O, Amblard F, Schinazi RF. In silico design of a novel nucleotide antiviral agent by free energy perturbation. Chem Biol Drug Des 2022;99:801-15. [PMID: 35313085 DOI: 10.1111/cbdd.14042] [Reference Citation Analysis]
10 Nishiyama T, Kobayashi T, Jirintai S, Nagashima S, Primadharsini PP, Nishizawa T, Okamoto H. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Antiviral Res. 2019;170:104570. [PMID: 31362004 DOI: 10.1016/j.antiviral.2019.104570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Dasari M, Ma P, Pelly SC, Sharma SK, Liotta DC. Synthesis and biological evaluation of 5'-C-methyl nucleotide prodrugs for treating HCV infections. Bioorg Med Chem Lett 2020;30:127539. [PMID: 32919013 DOI: 10.1016/j.bmcl.2020.127539] [Reference Citation Analysis]
12 Orr RK, Mccabe Dunn JM, Nolting A, Hyde AM, Ashley ER, Leone J, Sirota E, Jurica JA, Gibson A, Wise C, Oliver S, Ruck RT. New reactions and processes for the efficient synthesis of a HCV NS5b prodrug. Green Chem 2018;20:2519-25. [DOI: 10.1039/c8gc00102b] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ager CR, Zhang H, Wei Z, Jones P, Curran MA, Di Francesco ME. Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy. Bioorg Med Chem Lett 2019;29:126640. [PMID: 31500996 DOI: 10.1016/j.bmcl.2019.126640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
14 Slusarczyk M, Serpi M, Pertusati F. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antivir Chem Chemother 2018;26:2040206618775243. [PMID: 29792071 DOI: 10.1177/2040206618775243] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
15 Wang G, Dyatkina N, Prhavc M, Williams C, Serebryany V, Hu Y, Huang Y, Wan J, Wu X, Deval J, Fung A, Jin Z, Tan H, Shaw K, Kang H, Zhang Q, Tam Y, Stoycheva A, Jekle A, Smith DB, Beigelman L. Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. J Med Chem 2019;62:4555-70. [PMID: 30951311 DOI: 10.1021/acs.jmedchem.9b00143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
16 Asante-Appiah E, Liu R, Curry S, McMonagle P, Agrawal S, Carr D, Rokosz L, Lahser F, Bystol K, Chase R, Black S, Ferrari E, Ingravallo P, Tong L, Yu W, Kozlowski J. In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A. Antimicrob Agents Chemother 2018;62:e01280-18. [PMID: 30150466 DOI: 10.1128/AAC.01280-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]